MAFG - A Key Regulator in Melanoma Progression and a Potential Therapeutic Target

Explore the pivotal role of MAFG (MAF bZIP Transcription Factor G) in melanoma development and progression through this 48-minute research webinar presented by Dr. Olga Vera Puente from the Hospital La Paz Institute for Health Research in Madrid, Spain. Discover how MAFG expression correlates with melanoma stages and learn about groundbreaking research demonstrating that miRNA-29 suppresses melanoma development by repressing MAFG expression. Examine the frequent amplification and overexpression of MAFG in melanoma through TCGA analysis and understand how ectopic MAFG expression enhances malignant behavior in human melanoma cells across in vitro studies, xenograft models, and genetic mouse models of spontaneous melanoma. Investigate the molecular mechanisms by which MAFG induces a phenotype switch from melanocytic to dedifferentiated states and learn about its interaction with the lineage transcription factor MITF, which is essential for MAFG's pro-tumorigenic effects. Delve into MAFG's regulation of transcriptional programs associated with extracellular matrix remodeling and explore its potential as a therapeutic target for melanoma treatment. Gain insights from Dr. Vera's extensive research experience in epigenetic biomarkers, therapeutic targets, and mouse modeling in cancer, particularly her work on MAFG regulation and non-coding RNAs in melanoma developed through her research at both IdiPAZ and Moffitt Cancer Center.